Evidence map›Paper›PMID 40559439›Full record

ReviewMetabolites2025

Gadolinium in the Environment: A Double-Edged Sword for Plant Growth and Ecosystem Stability.

Marlena Tomczuk, Beata Godlewska-Żyłkiewicz, Andrzej Bajguz

Abstract readReview
In one paragraph

Review in Metabolites, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marlena TomczukDepartment of Biology and Plant Ecology, Faculty of Biology, University of Bialystok, Konstantego Ciołkowskiego 1J, 15-245 Bialystok, Poland.
Beata Godlewska-ŻyłkiewiczDepartment of Analytical and Inorganic Chemistry, Faculty of Chemistry, University of Bialystok, Konstantego Ciołkowskiego 1K, 15-245 Bialystok, Poland.ORCID 0000-0002-2576-4029
Andrzej BajguzDepartment of Biology and Plant Ecology, Faculty of Biology, University of Bialystok, Konstantego Ciołkowskiego 1J, 15-245 Bialystok, Poland.ORCID 0000-0003-4275-0881

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gadolinium, a rare earth element, is increasingly released into the environment due to its widespread applications in medical imaging, industry, and agriculture. This review explores the dual role of gadolinium in plant systems, highlighting its potential benefits at subtoxic concentrations and detrimental effects at higher levels. At subtoxic doses, gadolinium can enhance plant growth, metabolism, and stress tolerance by promoting enzymatic activity and nutrient absorption. However, elevated concentrations induce oxidative stress, disrupt nutrient uptake, and impair photosynthesis, leading to cellular damage and reduced growth. The bioaccumulation of gadolinium in plant tissues raises concerns about its trophic transfer within food chains and its broader ecological impact. Current evidence suggests that previously regarded as stable and inert gadolinium complexes can degrade under environmental conditions, increasing their bioavailability and toxicity. Despite its potential for agricultural applications, including improving crop resilience, the ecological risks associated with gadolinium remain poorly understood. Addressing these risks requires coordinated efforts to optimize gadolinium usage, develop advanced waste management strategies, and enhance monitoring of its environmental presence. This review emphasizes the need for in-depth research on gadolinium interactions with plants and ecosystems to balance its industrial benefits with environmental sustainability.

Indexed as

bioaccumulationgadolinium-based contrast agentshormetic effectplant growthrare earth elementtoxicity

Identifiers

PMID40559439
PMCPMC12195125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.